Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/29/20
End: 08/12/21
Due: 08/12/22
Phase: N/A
Priority: Normal
Start: 07/29/21
End: 09/23/22
Due: 09/23/23
Phase: N/A
Priority: Normal
Start: 08/31/20
End: 09/24/21
Due: 09/24/22
Phase: N/A
Priority: Normal
Start: 11/23/20
End: 02/01/22
Due: 02/01/23
Phase: N/A
Priority: Normal
Start: 02/26/18
End: 02/15/21
Due: 02/15/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of COVID-19 DNA Vaccine (AG0301-COVID19) | NCT04463472 | AnGes, Inc. | user2@example.com | None | 2020-06-29 | 2021-08-12 | 2022-08-12 | - | - | 2025-07-14 |
| Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) | NCT04993586 | AnGes, Inc. | user2@example.com | None | 2021-07-29 | 2022-09-23 | 2023-09-23 | - | - | 2025-07-14 |
| Study of COVID-19 DNA Vaccine (AG0302-COVID19) | NCT04527081 | AnGes, Inc. | user2@example.com | None | 2020-08-31 | 2021-09-24 | 2022-09-24 | - | - | 2025-07-14 |
| Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) | NCT04655625 | AnGes, Inc. | user2@example.com | None | 2020-11-23 | 2022-02-01 | 2023-02-01 | - | - | 2025-07-14 |
| AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain | NCT03263611 | AnGes, Inc. | user2@example.com | None | 2018-02-26 | 2021-02-15 | 2022-02-15 | - | - | 2025-07-14 |